₹ 254.00
-2.00 (-0.78%)
BSE
S
Samrat Pharmachem
₹ 254.00
BSE
SAMRATPH Financials Summary
Samrat Pharmachem revenue increased 13.01% quarter-on-quarter to ₹81 Cr in Jun 2026, while net profit turned positive at ₹1 Cr from a loss of ₹2 Cr in the previous quarter. Compared to the same quarter last year, revenue is up 5.90% and net profit turned positive at ₹1 Cr from a loss of ₹0 Cr a year ago. EPS for the quarter stood at ₹2.84, increased from -₹6.59 in the previous quarter and up from -₹0.74 a year ago.
Samrat Pharmachem Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Get In-depth View of SAMRATPH Quaterly Results, Balance Sheet, Cashflows & Corporate Action.
SAMRATPH Revenue Growth
All values are in Crores
Revenue
Profit
Loss

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






